Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Uveal Melanoma × CTLA-4 Antigen × Clear all

Phase

Phase 2 3 Phase 1 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Carcinoma, Renal Cell 1

Interventions

Vorinostat 1 Ipilimumab 1 Cyclophosphamide 1 Cryosurgery 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730157 2016-03-10

Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡